Table of Contents
1. Global collaborative R&D trends
- 1.1. Falling R&D productivity
- 1.1.1. Strategies adopted by global pharmaceutical companies to counter
falling R&D productivity
- 1.2. Look East trend
2. The Indian pharmaceutical industry
- 2.1. Overview
- 2.2. Market assessment
- 2.3. Key players in the Indian pharmaceutical market
3. An analysis of the regulatory environment and its implications for R&D
- 3.1. Regulation in the Indian pharmaceutical industry: A historical
perspective
- 3.2. The changing regulatory environment in India-Advantage R&D
- 3.3. An analysis of India's changing regulatory framework
- 3.3.1. Indian Patent Act, 1970
- 3.3.2. Patents Amendment Act, 2002
- 3.3.3. The Patents Amendment Ordinance, 2004
- 3.3.4. Indian Patents (Amendment) Act, 2005
- 3.3.5. New pharmaceutical policy (2006): Focus on R&D
- 3.3.5.1. Definitions of R&D
- 3.3.5.2. Technology upgrade funding
- 3.4. Response of MNCs to the changing regulatory environment
- 3.5. Implications for the Indian pharmaceutical industry
- 3.5.1. Collaborative and contract research and development
- 3.5.2. In- and out-licensing innovations
4. Collaborative R&D opportunities in India
- 4.1. Overview
- 4.2. Engagement models for licensing/purchasing innovation
- 4.3. Engagement models for contracting research services
- 4.4. NCE and NDDS research
- 4.5. Biopharma & drug discovery
- 4.5.1. Indian biopharma industry
- 4.5.1.1. Market size estimates: Indian biopharma industry
- 4.5.1.2. Indian biopharma industry: Vaccines segment
- 4.5.1.3. Indian biopharma industry: Therapeutics segment
- 4.5.1.4. Indian biopharma industry: Diagnostics segment
- 4.5.2. Drug discovery services
- 4.5.3. Indian biotechnology: Initiatives by the Department of
Biotechnology
- 4.5.3.1. National Biotechnology Development Strategy
- 4.5.3.1.1. Fiscal and trade policy initiatives
- 4.5.3.1.2. Financial incentives
- 4.5.3.1.3. Biotechnology parks
- 4.5.3.1.4. Regulatory mechanisms
- 4.5.3.1.5. Create a cadre of resource persons
- 4.5.3.1.6. Empowering a judiciary
- 4.5.3.1.7. Industrial mechanisms for strengthening public trust
- 4.5.3.1.8. Single window
- 4.5.3.1.9. Innovation
- 4.5.3.1.10. Strengthening technology transfer capacity
- 4.5.3.1.11 National Task Force on Education & Training
- 4.5.3.1.12 Needs assessment
- 4.5.3.2. Stem cell research policy
- 4.5.4. Major recent developments in biotechnology
- 4.6. Bioinformatics.
- 4.6.1. Market size estimates of Indian bioinformatics industry
- 4.6.2. Bioinformatics companies in India
- 4.6.3. Bioinformatics policy of India
- 4.6.4. Major recent developments in bioinformatics
- 4.7. Clinical research
- 4.7.1. Market size estimates of the Indian clinical research industry
- 4.7.2. Clinical trials: MNC focus on India
- 4.7.3. Government initiatives to boost clinical research in India
- 4.7.4. Outsourcing clinical data management to India
- 4.7.4.1. CROs
- 4.7.4.2. IT-pharmaceutical ventures
- 4.7.4.3. Other IT/ITES companies' bio-initiatives
5. Conclusions
6. Company profiles
- 6.1. NCE/NDDS
- 6.1.1. Dr Reddy's Laboratories Limited
- 6.1.1.1. Overview
- 6.1.1.2. R&D focus
- 6.1.1.3. Financials
- 6.1.1.4. Contact information
- 6.1.2. Glenmark Pharmaceuticals Ltd
- 6.1.2.1. Overview
- 6.1.2.2. R&D focus
- 6.1.2.3. Financials
- 6.1.2.4. Contact information
- 6.1.3. Lupin Limited
- 6.1.3.1. Overview
- 6.1.3.2. R&D focus
- 6.1.3.3. Financials
- 6.1.3.4. Contact information
- 6.1.4. Nicholas Piramal India Limited
- 6.1.4.1. Overview
- 6.1.4.2. R&D focus
- 6.1.4.3. R&D collaborations
- 6.1.4.4. Financials
- 6.1.4.5. Contact information
- 6.1.5. Ranbaxy Laboratories Limited
- 6.1.5.1. Overview
- 6.1.5.2. R&D focus
- 6.1.5.3. Financials
- 6.1.5.4. Contact information
- 6.1.6.Wockhardt Limited
- 6.1.6.1. Overview
- 6.1.6.2. R&D focus
- 6.1.6.3. Financials
- 6.1.6.4. Contact information
- 6.1.7. Zydus Cadila
- 6.1.7.1. Overview
- 6.1.7.2. R&D focus
- 6.1.7.3. Financials
- 6.1.7.4. Contact information
- 6.2. Bioinformatics
- 6.2.1. Avestha Gengraine Technologies Pvt. Ltd.
- 6.2.1.1. Overview
- 6.2.1.2. Products and services
- 6.2.1.3. Customer deals
- 6.2.1.4. Contact information
- 6.2.2. Jubilant Biosys Ltd
- 6.2.2.1. Overview
- 6.2.2.2. Products and services
- 6.2.2.3. Customer deals
- 6.2.2.4. Contact information
- 6.2.3. Molecular Connections Private Limited
- 6.2.3.1. Overview
- 6.2.3.2. Products and services
- 6.2.3.3. Customer deals
- 6.2.3.4. Contact information
- 6.2.4. Ocimum Biosolutions Ltd
- 6.2.4.1. Overview
- 6.2.4.2. Products and services
- 6.2.4.3. Customer deals
- 6.2.4.4. Contact information
- 6.2.5. Strand Genomics
- 6.2.5.1. Overview
- 6.2.5.2. Products and services
- 6.2.5.3. Customer deals
- 6.2.5.4. Contact information
- 6.2.6. SysArris Software Pvt. Ltd
- 6.2.6.1. Overview
- 6.2.6.2. Products and services
- 6.2.6.3. Customer deals
- 6.2.6.4. Contact information
- 6.2.7. Bigtec Private Ltd.
- 6.2.7.1. Overview
- 6.2.7.2. Products and services
- 6.2.7.3. Customer deals
- 6.2.7.4. Contact information
- 6.2.8. LabVantage Solutions Private Ltd
- 6.2.8.1. Overview
- 6.2.8.2. Products and services
- 6.2.8.3. Customer deals
- 6.2.8.4. Contact information
- 6.3. Biopharma & drug discovery services
- 6.3.1. Aurigene Discovery Technologies Limited
- 6.3.1.1. Overview
- 6.3.1.2. Products and services
- 6.3.1.3. Contact information
- 6.3.2. Syngene International Private Limited
- 6.3.2.1. Overview
- 6.3.2.2. Products and services
- 6.3.2.3. Customer deals
- 6.3.2.4. Contact information
- 6.3.3. Reliance Research and Development Services
- 6.3.3.1. Overview
- 6.3.3.2. Products and services
- 6.3.3.3. Contact information
- 6.3.4. Reliance Life Sciences
- 6.3.4.1. Overview
- 6.3.4.2. Products and services
- 6.3.4.3. Contact information
- 6.4. Clinical Research
- 6.4.1. Clinigene International Private Limited
- 6.4.1.1. Overview
- 6.4.1.2. Products and services
- 6.4.1.3. Contact information
- 6.4.2. iGATE Clinical Research International
- 6.4.2.1. Overview
- 6.4.2.2. Products and services
- 6.4.2.3. Contact information
- 6.4.3. SIRO Clinpharm Pvt. Ltd.
- 6.4.3.1. Overview
- 6.4.3.2. Products and services
- 6.4.3.3. Contact information
- 6.4.4. Wellquest CRO
- 6.4.4.1. Overview
- 6.4.4.2. Products and services
- 6.4.4.3. Contact information
- 6.4.5. Reliance Clinical Research Services
- 6.4.5.1. Overview
- 6.4.5.2. Products and services
- 6.4.5.3. Contact information
- 6.4.6. ClinTec International
- 6.4.6.1. Overview
- 6.4.6.2. Products and services
- 6.4.6.3. Contact information
- 6.4.7. Quintiles India
- 6.4.7.1. Overview
- 6.4.7.2. Products and services
- 6.4.7.3. Contact information
7. Life science research institute profiles
- 7.1. Central Drug Research Institute
- 7.1.1. Overview
- 7.1.2. R&D focus
- 7.1.3. R&D expertise and technical facilities
- 7.1.4. Collaborative opportunities
- 7.1.5. Products and technologies developed
- 7.1.5.1. Technologies developed
- 7.1.6. Pharmaceutical and biotechnology opportunities
- 7.1.7. Contact information
- 7.2. Indian Institute of Chemical Technology
- 7.2.1. Overview
- 7.2.2. R&D focus
- 7.2.3. R&D expertise and technical facilities
- 7.2.4. Collaborative opportunities
- 7.2.5. Products and technologies developed
- 7.2.6. Key collaborations
- 7.2.7. Contact information
- 7.3. National Chemical Laboratory
- 7.3.1. Overview
- 7.3.2. R&D focus
- 7.3.3. R&D expertise and technical facilities
- 7.3.4. Collaborative opportunities
- 7.3.5. Key collaborations
- 7.3.6. Contact information
- 7.4. Center for Cellular and Molecular Biology
- 7.4.1. Overview
- 7.4.2. R&D focus
- 7.4.3. R&D expertise and technical facilities
- 7.4.4. Collaborative opportunities
- 7.4.5. Products and technologies developed
- 7.4.6. Key collaborations
- 7.4.7. Contact information
- 7.5. Institute of Microbial Technology
- 7.5.1. Overview
- 7.5.2. R&D focus
- 7.5.3. R&D expertise and technical facilities
- 7.5.4. Collaborative opportunities
- 7.5.5. Products and technologies developed
- 7.5.6. Key collaborations
- 7.5.7. Contact information
8. Indian biotechnology: Regional Government initiatives
- 8.1. Orissa State (Eastern India)
- 8.1.1. Orissa biotechnology parks
- 8.2. West Bengal State (Eastern India)
- 8.3. Gujarat State (Western India)
- 8.3.1. International Pharma & Biotech Park, Ahmedabad
- 8.3.1.1. Contact information
- 8.3.2. Biotechnology park, Vadodra
- 8.4. Maharashtra State (Western India)
- 8.4.1. International Biotech Park, Pune
- 8.4.1.1. Contact information
- 8.4.2. Jalna Agri Biotech Park, Jalna
- 8.5. Punjab State (Northern India)
- 8.5.1. Punjab Biotech Park, Derabassi, near Chandigarh
- 8.5.1.1. Contact information
- 8.5.2. Other initiatives
- 8.6. Haryana State (Northern India)
- 8.7. Himachal Pradesh State (Northern India)
- 8.8. Rajasthan State (Northern India)
- 8.8.1. Biotechnology park at Sitapura-Jaipur
- 8.8.1.1. Contact information
- 8.8.2. Biotechnology park at Boranada, Jodhpur
- 8.8.3. Biotechnology park at Bhiwadi, Alwar
- 8.9. Uttar Pradesh State (Northern India
- 8.9.1. Lucknow biotechnology park, Lucknow
- 8.9.1.1. Contact information
- 8.9.2. Biotech City, NOIDA
- 8.10. Uttaranchal State (Northern India
- 8.10.1. Biotech park, Pantnagar
- 8.11. Madhya Pradesh State (Central India
- 8.12. Karnataka State (Southern India
- 8.12.1. Bangalore biotechnology park (Bangalore Helix)
- 8.12.1.1. Contact information
- 8.13. Kerala State (Southern India)
- 8.13.1. KINFRA biotech park, Kalamassery
- 8.13.1.1. Contact information
- 8.13.2. KINFRA biotechnology park, Trivandrum
- 8.14. Andhra Pradesh State (Southern India)
- 8.14.1. ICICI Knowledge Park, Turkapally
- 8.14.2. Shapoorji Pallonji Biotech Park, Genome Valley, Hyderabad
- 8.14.2.1. Contact information
- 8.15. Tamil Nadu State (Southern India)
- 8.15.1. TICEL Bio Park
- 8.15.1.1. Contact information
- 8.15.2. Mahindra Industrial Park, Mahindra City
- 8.15.1.2. Contact information
9. Appendices
- 9.1. References
- 9.2. References
- 9.3. Abbreviations
- 9.4. Glossary
- 9.5. Author biographies
- 9.5.1. Siraj Dhanani
- 9.5.2. Amit Sadana
- 9.5.3. Ashish Malik
- 9.5.4. PharmARC
|
Related Report
|
View Cart
